QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysis
IntroductionThirty oral targeted antineoplastic agents are associated with prolongation of the QT interval. However, limited data exists regarding QTc prolongation and associated risk factors in the ambulatory oncology setting.MethodsThis retrospective study was completed to describe QTc prolongatio...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1098333/full |